KSHV reactivation and novel implications of protein isomerization on lytic switch control

Viruses

Volumn 7, Issue 1, 2015, Pages 72-109

  Guito, Jonathan ^a   Lukac, David M ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Herpesvirus; Human herpesvirus 8; Kaposi s sarcoma associated herpesvirus; Peptidyl prolyl cis trans isomerase; Pin1; Reactivation; Rta; Transcriptional activation

Indexed keywords

NOTCH RECEPTOR; OCTAMER TRANSCRIPTION FACTOR 1; PEPTIDYLPROLYL ISOMERASE PIN1; PROTEIN; RECOMBINING BINDING PROTEIN SUPPRESSOR OF HAIRLESS; REPLICATION AND TRANSCRIPTION ACTIVATOR PROTEIN; UNCLASSIFIED DRUG; VIRAL MTA PROTEIN; IMMEDIATE EARLY PROTEIN; NIMA-INTERACTING PEPTIDYLPROLYL ISOMERASE; PEPTIDYLPROLYL ISOMERASE; RTA PROTEIN, HUMAN HERPESVIRUS 8; TRANSACTIVATOR PROTEIN;

CELL CYCLE REGULATION; DNA REPLICATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN HERPESVIRUS 8; HUMAN T CELL LEUKEMIA VIRUS 1; ISOMERIZATION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; VIRION; VIRUS CARCINOGENESIS; VIRUS LATENCY; VIRUS REACTIVATION; VIRUS REPLICATION; GENE EXPRESSION REGULATION; HOST PATHOGEN INTERACTION; HUMAN; METABOLISM; PHYSIOLOGY; VIRUS ACTIVATION;

HERPESVIRIDAE; HUMAN HERPESVIRUS 8;

GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 8, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMEDIATE-EARLY PROTEINS; PEPTIDYLPROLYL ISOMERASE; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 84921290772     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v7010072     Document Type: Review

References (184)

1. Neipel, F.; Albrecht, J.C.; Fleckenstein, B. Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: Determinants of its pathogenicity? J. Virol. 1997, 71, 4187-4192.
2. Dourmishev, L.A.; Dourmishev, A.L.; Palmeri, D.; Schwartz, R.A.; Lukac, D.M. Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis. Microbiol. Mol. Biol. Rev. 2003, 67, 175-212, table of contents.
3. Edelman, D.C. Human herpesvirus 8-A novel human pathogen. Virol. J. 2005, 2, 78.
4. Ganem, D. Kaposi's sarcoma-associated herpesvirus. In Fields Virology; Knipe, D.M., Howley, P.M., Eds.; Lippincott Williams and Wilkins: Philadelphia, PA, USA,2007; Volume 2, pp. 2848-2888.
5. Wen, K.W.; Damania, B. Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis. Cancer Lett. 2010, 289, 140-150.
6. Hengge, U.R.; Ruzicka, T.; Tyring, S.K.; Stuschke, M.; Roggendorf, M.; Schwartz, R.A.; Seeber, S. Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: Epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet Infect. Dis. 2002, 2, 281-292.
7. Lukac, D.M.; Yuan, Y. Reactivation and lytic replication of KSHV. In Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis; Arvin, A., Campadelli-Fiume, G., Mocarski, E., Moore, P.S., Roizman, B., Whitley, R., Yamanishi, K., Eds.; Cambridge University Press: Cambridge, UK, 2007; pp. 434-460.
8. Ruocco, E.; Ruocco, V.; Tornesello, M.L.; Gambardella, A.; Wolf, R.; Buonaguro, F.M. Kaposi's sarcoma: Etiology and pathogenesis, inducing factors, causal associations, and treatments: facts and controversies. Clin. Dermatol. 2013, 31, 413-422.
9. Sathish, N.; Wang, X.; Yuan, Y. Tegument Proteins of Kaposi's Sarcoma-Associated Herpesvirus and Related Gamma-Herpesviruses. Front. Microbiol. 2012, 3, 98.
10. Greene, W.; Kuhne, K.; Ye, F.; Chen, J.; Zhou, F.; Lei, X.; Gao, S.J. Molecular biology of KSHV in relation to AIDS-associated oncogenesis. Cancer Treat. Res. 2007, 133, 69-127.
11. Hengge, U.R.; Ruzicka, T.; Tyring, S.K.; Stuschke, M.; Roggendorf, M.; Schwartz, R.A.; Seeber, S. Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 2: Pathogenesis, Castleman's disease, and pleural effusion lymphoma. Lancet Infect. Dis. 2002, 2, 344-352.
12. Chen, Y.B.; Rahemtullah, A.; Hochberg, E. Primary effusion lymphoma. Oncologist 2007, 12, 569-576.
13. Noguchi, K.; Fukazawa, H.; Murakami, Y.; Takahashi, N.; Yamagoe, S.; Uehara, Y. Gamma-herpesviruses and cellular signaling in AIDS-associated malignancies. Cancer Sci. 2007, 98, 1288-1296.
14. Ye, F.; Lei, X.; Gao, S.J. Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus Latency and Reactivation. Adv. Virol. 2011, 2011, doi:10.1155/2011/193860.
15. Dittmer, D.P.; Damania, B. Kaposi sarcoma associated herpesvirus pathogenesis (KSHV)-an update. Curr. Opin. Virol. 2013, 3, 238-244.
16. Scholz, B.A.; Harth-Hertle, M.L.; Malterer, G.; Haas, J.; Ellwart, J.; Schulz, T.F.; Kempkes, B. Abortive lytic reactivation of KSHV in CBF1/CSL deficient human B cell lines. PLoS Pathog. 2013, 9, e1003336.
17. Sun, R.; Lin, S.-F.; Staskus, K.; Gradoville, L.; Grogan, E.; Haase, A.; Miller, G. Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression. J. Virol. 1999, 73, 2232-2242.
18. Sternbach, G.; Varon, J. Moritz Kaposi: Idiopathic pigmented sarcoma of the skin. J. Emerg. Med. 1995, 13, 671-674.
19. Rezza, G.; Lennette, E.T.; Giuliani, M.; Pezzotti, P.; Caprilli, F.; Monini, P.; Butto, S.; Lodi, G.; Di Carlo, A.; Levy, J.A.; Ensoli, B. Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infections. Int. J. Cancer 1998, 77, 361-365.
20. Lu, F.; Zhou, J.; Wiedmer, A.; Madden, K.; Yuan, Y.; Lieberman, P.M. Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency. J. Virol. 2003, 77, 11425-11435.
21. Pantry, S.N.; Medveczky, P.G. Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus replication. Semin. Cancer Biol. 2009, 19, 153-157.
22. Sathish, N.; Zhu, F.X.; Yuan, Y. Kaposi's sarcoma-associated herpesvirus ORF45 interacts with kinesin-2 transporting viral capsid-tegument complexes along microtubules. PLoS Pathog. 2009, 5, e1000332.
23. Subramanian, R.; Sehgal, I.; D'Auvergne, O.; Kousoulas, K.G. Kaposi's sarcoma-associated herpesvirus glycoproteins B and K8.1 regulate virion egress and synthesis of vascular endothelial growth factor and viral interleukin-6 in BCBL-1 cells. J. Virol. 2010, 84, 1704-1714.
24. Montaner, S.; Sodhi, A.; Molinolo, A.; Bugge, T.H.; Sawai, E.T.; He, Y.; Li, Y.; Ray, P.E.; Gutkind, J.S. Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes. Cancer Cell 2003, 3, 23-36.
25. Liang, C.; Lee, J.S.; Jung, J.U. Immune evasion in Kaposi's sarcoma-associated herpes virus associated oncogenesis. Semin. Cancer Biol. 2008, 18, 423-436.
26. Areste, C.; Blackbourn, D.J. Modulation of the immune system by Kaposi's sarcoma-associated herpesvirus. Trends Microbiol. 2009, 17, 119-129.
27. Damania, B. Oncogenic gamma-herpesviruses: Comparison of viral proteins involved in tumorigenesis. Nat. Rev. Microbiol. 2004, 2, 656-668.
28. Mutlu, A.D.; Cavallin, L.E.; Vincent, L.; Chiozzini, C.; Eroles, P.; Duran, E.M.; Asgari, Z.; Hooper, A.T.; La Perle, K.M.; Hilsher, C.; Gao, S.J.; Dittmer, D.P.; Rafii, S.; Mesri, E.A. In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: A cell and animal model of virally induced Kaposi's sarcoma. Cancer Cell 2007, 11, 245-258.
29. Montaner, S.; Sodhi, A.; Ramsdell, A.K.; Martin, D.; Hu, J.; Sawai, E.T.; Gutkind, J.S. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma. Cancer Res. 2006, 66, 168-174.
30. Zong, J.C.; Ciufo, D.M.; Alcendor, D.J.; Wan, X.; Nicholas, J.; Browning, P.J.; Rady, P.L.; Tyring, S.K.; Orenstein, J.M.; Rabkin, C.S.; et al. High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations. J. Virol. 1999, 73, 4156-4170.
31. Polson, A.G.; Wang, D.; DeRisi, J.; Ganem, D. Modulation of host gene expression by the constitutively active G protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus. Cancer Res. 2002, 62, 4525-4530.
32. Lagunoff, M.; Lukac, D.M.; Ganem, D. Immunoreceptor tyrosine-based activation motif-dependent signaling by Kaposi's sarcoma-associated herpesvirus K1 protein: Effects on lytic viral replication. J. Virol. 2001, 75, 5891-5898.
33. Moore, P.S.; Boshoff, C.; Weiss, R.A.; Chang, Y. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 1996, 274, 1739-1744.
34. Lukac, D.M.; Renne, R.; Kirshner, J.R.; Ganem, D. Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology 1998, 252, 304-312.
35. Lukac, D.M.; Kirshner, J.R.; Ganem, D. Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. J. Virol. 1999, 73, 9348-9361.
36. Xu, Y.; AuCoin, D.P.; Huete, A.R.; Cei, S.A.; Hanson, L.J.; Pari, G.S. A Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50 deletion mutant is defective for reactivation of latent virus and DNA replication. J. Virol. 2005, 79, 3479-3487.
37. Guito, J.; Lukac, D.M. KSHV Rta Promoter Specification and Viral Reactivation. Front. Microbiol. 2012, 3, 30.
38. Chen, J.; Ye, F.; Xie, J.; Kuhne, K.; Gao, S.J. Genome-wide identification of binding sites for Kaposi's sarcoma-associated herpesvirus lytic switch protein, RTA. Virology 2009, 386, 290-302.
39. Carroll, K.D.; Khadim, F.; Spadavecchia, S.; Palmeri, D.; Lukac, D.M. Direct interactions of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50/Rta protein with the cellular protein octamer-1 and DNA are critical for specifying transactivation of a delayed-early promoter and stimulating viral reactivation. J. Virol. 2007, 81, 8451-8467.
40. Damania, B.; Jeong, J.H.; Bowser, B.S.; DeWire, S.M.; Staudt, M.R.; Dittmer, D.P. Comparison of the Rta/Orf50 transactivator proteins of gamma-2-herpesviruses. J. Virol. 2004, 78, 5491-5499.
41. Kieff, E.; Rickinson, A.B. Epstein-Barr virus and its replication. In Fields Virology, 5th ed.; David, K.M., Ed.; Lippincott-Raven Publishers: Philadelphia, PA, USA, 2007.
42. Campbell, M.; Izumiya, Y. Post-Translational Modifications of Kaposi's Sarcoma-Associated Herpesvirus Regulatory Proteins-SUMO and KSHV. Front. Microbiol. 2012, 3, 31.
43. Ko, Y.C.; Tsai, W.H.; Wang, P.W.; Wu, I.L.; Lin, S.Y.; Chen, Y.L.; Chen, J.Y.; Lin, S.F. Suppressive regulation of KSHV RTA with O-GlcNAcylation. J. Biomed. Sci. 2012, 19, 12.
44. Tsai, W.H.; Wang, P.W.; Lin, S.Y.; Wu, I.L.; Ko, Y.C.; Chen, Y.L.; Li, M.; Lin, S.F. Ser-634 and Ser-636 of Kaposi's Sarcoma-Associated Herpesvirus RTA are Involved in Transactivation and are Potential Cdk9 Phosphorylation Sites. Front. Microbiol. 2012, 3, 60.
45. Gwack, Y.; Nakamura, H.; Lee, S.H.; Souvlis, J.; Yustein, J.T.; Gygi, S.; Kung, H.J.; Jung, J.U. Poly(ADP-ribose) polymerase 1 and Ste20-like kinase hKFC act as transcriptional repressors for gamma-2 herpesvirus lytic replication. Mol. Cell Biol. 2003, 23, 8282-8294.
46. West, J.T.; Wood, C. The role of Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 regulator of transcription activation (RTA) in control of gene expression. Oncogene 2003, 22, 5150-5163.
47. Carroll, K.D.; Bu, W.; Palmeri, D.; Spadavecchia, S.; Lynch, S.J.; Marras, S.A.; Tyagi, S.; Lukac, D.M. Kaposi's Sarcoma-associated herpesvirus lytic switch protein stimulates DNA binding of RBP-Jk/CSL to activate the Notch pathway. J. Virol. 2006, 80, 9697-9709.
48. Liang, Y.; Chang, J.; Lynch, S.; Lukac, D.M.; Ganem, D. The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jk, the target of the Notch signaling pathway. Genes Dev. 2002, 16, 1977-1989.
49. Liang, Y.; Ganem, D. Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling. Proc. Natl. Acad. Sci. USA 2003, 100, 8490-8495.
50. Palmeri, D.; Spadavecchia, S.; Carroll, K.D.; Lukac, D.M. Promoter-and cell-specific transcriptional transactivation by the Kaposi's sarcoma-associated herpesvirus ORF57/Mta protein. J. Virol. 2007, 81, 13299-13314.
51. Papugani, A.; Coleman, T.; Jones, C.; Zhang, L. The interaction between KSHV RTA and cellular RBP-Jkappa and their subsequent DNA binding are not sufficient for activation of RBP-Jkappa. Virus Res. 2008, 131, 1-7.
52. Gwack, Y.; Byun, H.; Hwang, S.; Lim, C.; Choe, J. CREB-binding protein and histone deacetylase regulate the transcriptional activity of Kaposi's sarcoma-associated herpesvirus open reading frame 50. J. Virol. 2001, 75, 1909-1917.
53. Lukac, D.M.; Garibyan, L.; Kirshner, J.R.; Palmeri, D.; Ganem, D. DNA binding by Kaposi's sarcoma-associated herpesvirus lytic switch protein is necessary for transcriptional activation of two viral delayed early promoters. J. Virol. 2001, 75, 6786-6799.
54. Bu, W.; Carroll, K.D.; Palmeri, D.; Lukac, D.M. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50/Rta lytic switch protein functions as a tetramer. J. Virol. 2007, 81, 5788-5806.
55. Palmeri, D.; Carroll, K.D.; Gonzalez-Lopez, O.; Lukac, D.M. Kaposi's sarcoma-associated herpesvirus Rta tetramers make high-affinity interactions with repetitive DNA elements in the Mta promoter to stimulate DNA binding of RBP-Jk/CSL. J. Virol. 2011, 85, 11901-11915.
56. Ziegelbauer, J.; Grundhoff, A.; Ganem, D. Exploring the DNA binding interactions of the Kaposi's sarcoma-associated herpesvirus lytic switch protein by selective amplification of bound sequences in vitro. J. Virol. 2006, 80, 2958-2967.
57. Bu, W.; Palmeri, D.; Krishnan, R.; Marin, R.; Aris, V.M.; Soteropoulos, P.; Lukac, D.M. Identification of direct transcriptional targets of the Kaposi's sarcoma-associated herpesvirus Rta lytic switch protein by conditional nuclear localization. J. Virol. 2008, 82, 10709-10723.
58. Song, M.J.; Li, X.; Brown, H.J.; Sun, R. Characterization of interactions between RTA and the promoter of polyadenylated nuclear RNA in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. J. Virol. 2002, 76, 5000-5013.
59. Sun, R.; Lin, S.; Gradoville, L.; Miller, G. Polyadenylated nuclear RNA encoded by Kaposi's sarcoma-associated herpesvirus. Proc. Natl. Acad. Sci. USA 1996, 93, 11883-11888.
60. Borah, S.; Darricarrere, N.; Darnell, A.; Myoung, J.; Steitz, J.A. A viral nuclear noncoding RNA binds re-localized poly(A) binding protein and is required for late KSHV gene expression. PloS Pathog. 2011, 7, e1002300.
61. Wang, Y.; Li, H.; Chan, M.Y.; Zhu, F.X.; Lukac, D.M.; Yuan, Y. Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: Cis-acting requirements for replication and ori-Lyt-associated RNA transcription. J. Virol. 2004, 78, 8615-8629.
62. Gwack, Y.; Hwang, S.; Byun, H.; Lim, C.; Kim, J.W.; Choi, E.J.; Choe, J. Kaposi's sarcoma-associated herpesvirus open reading frame 50 represses p53-induced transcriptional activity and apoptosis. J. Virol. 2001, 75, 6245-6248.
63. Yang, Z.; Wood, C. The transcriptional repressor K-RBP modulates RTA-mediated transactivation and lytic replication of Kaposi's sarcoma-associated herpesvirus. J. Virol. 2007, 81, 6294-6306.
64. Yang, Z.; Yan, Z.; Wood, C. Kaposi's sarcoma-associated herpesvirus transactivator RTA promotes degradation of the repressors to regulate viral lytic replication. J. Virol. 2008, 82, 3590-3603.
65. Yang, Z.; Wen, H.J.; Minhas, V.; Wood, C. The zinc finger DNA-binding domain of K-RBP plays an important role in regulating Kaposi's sarcoma-associated herpesvirus RTA-mediated gene expression. Virology 2009, 391, 221-231.
66. Yu, Y.; Wang, S.E.; Hayward, G.S. The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated degradation. Immunity 2005, 22, 59-70.
67. Izumiya, Y.; Lin, S.F.; Ellison, T.; Chen, L.Y.; Izumiya, C.; Luciw, P.; Kung, H.J. Kaposi's sarcoma-associated herpesvirus K-bZIP is a coregulator of K-Rta: physical association and promoter-dependent transcriptional repression. J. Virol. 2003, 77, 1441-1451.
68. Gould, F.; Harrison, S.M.; Hewitt, E.W.; Whitehouse, A. Kaposi's sarcoma-associated herpesvirus RTA promotes degradation of the Hey1 repressor protein through the ubiquitin proteasome pathway. J. Virol. 2009, 83, 6727-6738.
69. Cai, Q.; Lan, K.; Verma, S.C.; Si, H.; Lin, D.; Robertson, E.S. Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: Latency control under low oxygen conditions. J. Virol. 2006, 80, 7965-7975.
70. Verma, S.C.; Lan, K.; Robertson, E. Structure and function of latency-associated nuclear antigen. Curr. Top. Microbiol. Immunol. 2007, 312, 101-136.
71. Ballestas, M.E.; Kaye, K.M. The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency. Future Microbiol. 2011, 6, 1399-1413.
72. Lan, K.; Kuppers, D.A.; Robertson, E.S. Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway. J. Virol. 2005, 79, 3468-3478.
73. Li, Q.; Zhou, F.; Ye, F.; Gao, S.J. Genetic disruption of KSHV major latent nuclear antigen LANA enhances viral lytic transcriptional program. Virology 2008, 379, 234-244.
74. Shin, H.J.; DeCotiis, J.; Giron, M.; Palmeri, D.; Lukac, D.M. Histone deacetylase classes I and II regulate Kaposi's sarcoma-associated herpesvirus reactivation. J. Virol. 2014, 88, 1281-1292.
75. Qin, Z.; Jakymiw, A.; Findlay, V.; Parsons, C. KSHV-Encoded MicroRNAs: Lessons for Viral Cancer Pathogenesis and Emerging Concepts. Int. J. Cell Biol. 2012, 2012, 603961.
76. Samols, M.A.; Skalsky, R.L.; Maldonado, A.M.; Riva, A.; Lopez, M.C.; Baker, H.V.; Renne, R. Identification of cellular genes targeted by KSHV-encoded microRNAs. PLoS Pathog. 2007, 3, e65.
77. Ganem, D.; Ziegelbauer, J. MicroRNAs of Kaposi's sarcoma-associated herpes virus. Semin. Cancer Biol. 2008, 18, 437-440.
78. Bellare, P.; Ganem, D. Regulation of KSHV lytic switch protein expression by a virus-encoded microRNA: An evolutionary adaptation that fine-tunes lytic reactivation. Cell Host Microbe 2009, 6, 570-575.
79. Ye, F.C.; Zhou, F.C.; Xie, J.P.; Kang, T.; Greene, W.; Kuhne, K.; Lei, X.F.; Li, Q.H.; Gao, S.J. Kaposi's sarcoma-associated herpesvirus latent gene vFLIP inhibits viral lytic replication through NF-kappaB-mediated suppression of the AP-1 pathway: A novel mechanism of virus control of latency. J. Virol. 2008, 82, 4235-4249.
80. Izumiya, Y.; Izumiya, C.; Hsia, D.; Ellison, T.J.; Luciw, P.A.; Kung, H.J. NF-kappaB serves as a cellular sensor of Kaposi's sarcoma-associated herpesvirus latency and negatively regulates K-Rta by antagonizing the RBP-Jkappa coactivator. J. Virol. 2009, 83, 4435-4446.
81. Wang, S.E.; Wu, F.Y.; Chen, H.; Shamay, M.; Zheng, Q.; Hayward, G.S. Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, and MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway. J. Virol. 2004, 78, 4248-4267.
82. He, Z.; Liu, Y.; Liang, D.; Wang, Z.; Robertson, E.S.; Lan, K. Cellular corepressor TLE2 inhibits replication-and-transcription-activator-mediated transactivation and lytic reactivation of Kaposi's sarcoma-associated herpesvirus. J. Virol. 2010, 84, 2047-2062.
83. Chang, P.J.; Miller, G. Autoregulation of DNA binding and protein stability of Kaposi's sarcoma-associated herpesvirus ORF50 protein. J. Virol. 2004, 78, 10657-10673.
84. Chang, P.J.; Shedd, D.; Miller, G. A mobile functional region of Kaposi's sarcoma-associated herpesvirus ORF50 protein independently regulates DNA binding and protein abundance. J. Virol. 2008, 82, 9700-9716.
85. Peng, L.; Wu, T.T.; Tchieu, J.H.; Feng, J.; Brown, H.J.; Feng, J.; Li, X.; Qi, J.; Deng, H.; Vivanco, I.; Mellinghoff, I.K.; Jamieson, C.; Sun, R. Inhibition of the phosphatidylinositol 3-kinase-Akt pathway enhances gamma-2 herpesvirus lytic replication and facilitates reactivation from latency. J. Gen. Virol. 2010, 91, 463-469.
86. Cheng, F.; Weidner-Glunde, M.; Varjosalo, M.; Rainio, E.M.; Lehtonen, A.; Schulz, T.F.; Koskinen, P.J.; Taipale, J.; Ojala, P.M. KSHV reactivation from latency requires Pim-1 and Pim-3 kinases to inactivate the latency-associated nuclear antigen LANA. PLoS Pathog. 2009, 5, e1000324.
87. Sandford, G.; Choi, Y.B.; Nicholas, J. Role of ORF74-encoded viral G protein-coupled receptor in human herpesvirus 8 lytic replication. J. Virol. 2009, 83, 13009-13014.
88. Bottero, V.; Sharma-Walia, N.; Kerur, N.; Paul, A.G.; Sadagopan, S.; Cannon, M.; Chandran, B. Kaposi sarcoma-associated herpes virus (KSHV) G protein-coupled receptor (vGPCR) activates the ORF50 lytic switch promoter: A potential positive feedback loop for sustained ORF50 gene expression. Virology 2009, 392, 34-51.
89. Davis, D.A.; Rinderknecht, A.S.; Zoeteweij, J.P.; Aoki, Y.; Read-Connole, E.L.; Tosato, G.; Blauvelt, A.; Yarchoan, R. Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus. Blood 2001, 97, 3244-3250.
90. Haque, M.; Davis, D.A.; Wang, V.; Widmer, I.; Yarchoan, R. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) contains hypoxia response elements: relevance to lytic induction by hypoxia. J. Virol. 2003, 77, 6761-6768.
91. Wilson, S.J.; Tsao, E.H.; Webb, B.L.; Ye, H.; Dalton-Griffin, L.; Tsantoulas, C.; Gale, C.V.; Du, M.Q.; Whitehouse, A.; Kellam, P. X box binding protein XBP-1s transactivates the Kaposi's sarcoma-associated herpesvirus (KSHV) ORF50 promoter, linking plasma cell differentiation to KSHV reactivation from latency. J. Virol. 2007, 81, 13578-13586.
92. Dalton-Griffin, L.; Wilson, S.J.; Kellam, P. X-box binding protein 1 contributes to induction of the Kaposi's sarcoma-associated herpesvirus lytic cycle under hypoxic conditions. J. Virol. 2009, 83, 7202-7209.
93. Huang, Y.T.; Lin, J.K.; Lee, M.T. Inhibition of 12-O-tetradecanoylphorbol-13-acetate induction of c-fos mRNA by the protein kinase A inhibitor N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinoline sulfonamide. Biochem. Pharmacol. 1999, 58, 1639-1647.
94. Gwack, Y.; Hwang, S.; Lim, C.; Won, Y.S.; Lee, C.H.; Choe, J. Kaposi's Sarcoma-associated herpesvirus open reading frame 50 stimulates the transcriptional activity of STAT3. J. Biol. Chem. 2002, 277, 6438-6442.
95. Spadavecchia, S.; Palmeri, D.; Lukac, D.M. KSHV Mta protein stimulates transcriptional elongation. 2009, to be submitted for publication.
96. Conrad, N.K. Posttranscriptional gene regulation in Kaposi's sarcoma-associated herpesvirus. Adv. Appl. Microbiol. 2009, 68, 241-261.
97. Artavanis-Tsakonas, S.; Rand, M.D.; Lake, R.J. Notch signaling: Cell fate control and signal integration in development. Science 1999, 284, 770-776.
98. Liu, Z.J.; Shirakawa, T.; Li, Y.; Soma, A.; Oka, M.; Dotto, G.P.; Fairman, R.M.; Velazquez, O.C.; Herlyn, M. Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis. Mol. Cell Biol. 2003, 23, 14-25.
99. Curry, C.L.; Reed, L.L.; Broude, E.; Golde, T.E.; Miele, L.; Foreman, K.E. Notch inhibition in Kaposi's sarcoma tumor cells leads to mitotic catastrophe through nuclear factor-kappaB signaling. Mol. Cancer Ther. 2007, 6, 1983-1992.
100. Liu, R.; Li, X.; Tulpule, A.; Zhou, Y.; Scehnet, J.S.; Zhang, S.; Lee, J.S.; Chaudhary, P.M.; Jung, J.; Gill, P.S. KSHV-induced notch components render endothelial and mural cell characteristics and cell survival. Blood 2010, 115, 887-895.
101. Emuss, V.; Lagos, D.; Pizzey, A.; Gratrix, F.; Henderson, S.R.; Boshoff, C. KSHV manipulates Notch signaling by DLL4 and JAG1 to alter cell cycle genes in lymphatic endothelia. PloS Pathog. 2009, 5, e1000616.
102. Curry, C.L.; Reed, L.L.; Golde, T.E.; Miele, L.; Nickoloff, B.J.; Foreman, K.E. Gamma secretase inhibitor blocks Notch activation and induces apoptosis in Kaposi's sarcoma tumor cells. Oncogene 2005, 24, 6333-6344.
103. Lan, K.; Choudhuri, T.; Murakami, M.; Kuppers, D.A.; Robertson, E.S. Intracellular activated Notch1 is critical for proliferation of Kaposi's sarcoma-associated herpesvirus-associated B-lymphoma cell lines in vitro. J. Virol. 2006, 80, 6411-6419.
104. Lan, K.; Murakami, M.; Choudhuri, T.; Kuppers, D.A.; Robertson, E.S. Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency. Virology 2006, 351, 393-403.
105. Gonzalez-Lopez, O.; Palmeri, D.; Lukac, D.M. Comprehensive analysis of DNA sequences required for KSHV Rta to stimulate DNA binding of the Notch effector RBP-Jk. 2015, to be submitted for publication.
106. Ellison, T.J.; Izumiya, Y.; Izumiya, C.; Luciw, P.A.; Kung, H.J. A comprehensive analysis of recruitment and transactivation potential of K-Rta and K-bZIP during reactivation of Kaposi's sarcoma-associated herpesvirus. Virology 2009, 387, 76-88.
107. Spadavecchia, S.; Gonzalez-Lopez, O.; Carroll, K.D.; Palmeri, D.; Lukac, D.M. Convergence of Kaposi's sarcoma-associated herpesvirus reactivation with Epstein-Barr virus latency and cellular growth mediated by the notch signaling pathway in coinfected cells. J. Virol. 2010, 84, 10488-10500.
108. Schaefer, M.H.; Wanker, E.E.; Andrade-Navarro, M.A. Evolution and function of CAG/polyglutamine repeats in protein-protein interaction networks. Nucleic Acids Res. 2012, 40, 4273-4287.
109. Williamson, M.P. The structure and function of proline-rich regions in proteins. Biochem. J. 1994, 297, 249-260.
110. Chang, M.; Brown, H.J.; Collado-Hidalgo, A.; Arevalo, J.M.; Galic, Z.; Symensma, T.L.; Tanaka, L.; Deng, H.; Zack, J.A.; Sun, R.; Cole, S.W. beta-Adrenoreceptors reactivate Kaposi's sarcoma-associated herpesvirus lytic replication via PKA-dependent control of viral RTA. J. Virol. 2005, 79, 13538-13547.
111. Gothel, S.F.; Marahiel, M.A. Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts. Cell Mol. Life Sci. 1999, 55, 423-436.
112. Anfinsen, C.B. Principles that govern the folding of protein chains. Science 1973, 181, 223-230.
113. Schmid, F.X. Protein folding. Prolyl isomerases join the fold. Curr. Biol. 1995, 5, 993-994.
114. Dolinski, K.; Muir, S.; Cardenas, M.; Heitman, J. All cyclophilins and FK506 binding proteins are, individually and collectively, dispensable for viability in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 1997, 94, 13093-13098.
115. Lu, K.P.; Finn, G.; Lee, T.H.; Nicholson, L.K. Prolyl cis-trans isomerization as a molecular timer. Nat. Chem. Biol. 2007, 3, 619-629.
116. Scholz, C.; Rahfeld, J.; Fischer, G.; Schmid, F.X. Catalysis of protein folding by parvulin. J. Mol. Biol. 1997, 273, 752-762.
117. Pavlov, M.Y.; Watts, R.E.; Tan, Z.; Cornish, V.W.; Ehrenberg, M.; Forster, A.C. Slow peptide bond formation by proline and other N-alkylamino acids in translation. Proc. Natl. Acad. Sci. USA 2009, 106, 50-54.
118. Lee, S.; Tsai, F.T. Molecular chaperones in protein quality control. J. Biochem. Mol. Biol. 2005, 38, 259-265.
119. Lu, K.P. Pinning down cell signaling, cancer and Alzheimer's disease. Trends Biochem. Sci. 2004, 29, 200-209.
120. Frausto, S.D.; Lee, E.; Tang, H. Cyclophilins as modulators of viral replication. Viruses 2013, 5, 1684-1701.
121. Lu, K.P.; Hanes, S.D.; Hunter, T. A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 1996, 380, 544-547.
122. O'Connell, M.J.; Krien, M.J.; Hunter, T. Never say never. The NIMA-related protein kinases in mitotic control. Trends Cell Biol. 2003, 13, 221-228.
123. Ranganathan, R.; Lu, K.P.; Hunter, T.; Noel, J.P. Structural and functional analysis of the mitotic rotamase Pin1 suggests substrate recognition is phosphorylation dependent. Cell 1997, 89, 875-886.
124. Shen, M.; Haggblom, C.; Vogt, M.; Hunter, T.; Lu, K.P. Characterization and cell cycle regulation of the related human telomeric proteins Pin2 and TRF1 suggest a role in mitosis. Proc. Natl. Acad. Sci. USA 1997, 94, 13618-13623.
125. Lee, T.H.; Perrem, K.; Harper, J.W.; Lu, K.P.; Zhou, X.Z. The F-box protein FBX4 targets PIN2/TRF1 for ubiquitin-mediated degradation and regulates telomere maintenance. J. Biol. Chem. 2006, 281, 759-768.
126. Takahashi, K.; Uchida, C.; Shin, R.W.; Shimazaki, K.; Uchida, T. Prolyl isomerase, Pin1: New findings of post-translational modifications and physiological substrates in cancer, asthma and Alzheimer's disease. Cell Mol Life Sci. 2008, 65, 359-375.
127. Lu, K.P.; Zhou, X.Z. The prolyl isomerase PIN1: A pivotal new twist in phosphorylation signalling and disease. Nat. Rev. Mol. Cell Biol. 2007, 8, 904-916.
128. Hanes, S.D. The Ess1 prolyl isomerase: Traffic cop of the RNA polymerase II transcription cycle. Biochim. Biophys. Acta 2014, 1839, 316-333.
129. Scholz, C.; Scherer, G.; Mayr, L.M.; Schindler, T.; Fischer, G.; Schmid, F.X. Prolyl isomerases do not catalyze isomerization of non-prolyl peptide bonds. Biol. Chem. 1998, 379, 361-365.
130. Lu, K.P.; Liou, Y.C.; Zhou, X.Z. Pinning down proline-directed phosphorylation signaling. Trends Cell Biol. 2002, 12, 164-172.
131. Kojima, Y.; Ryo, A. Pinning down viral proteins: A new prototype for virus-host cell interaction. Front. Microbiol. 2010, 1, 107.
132. Wulf, G.; Finn, G.; Suizu, F.; Lu, K.P. Phosphorylation-specific prolyl isomerization: is there an underlying theme? Nat. Cell Biol. 2005, 7, 435-441.
133. Liou, Y.C.; Zhou, X.Z.; Lu, K.P. Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins. Trends Biochem. Sci. 2011, 36, 501-514.
134. Wulf, G.M.; Ryo, A.; Wulf, G.G.; Lee, S.W.; Niu, T.; Petkova, V.; Lu, K.P. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. EMBO J. 2001, 20, 3459-3472.
135. Bao, L.; Kimzey, A.; Sauter, G.; Sowadski, J.M.; Lu, K.P.; Wang, D.G. Prevalent overexpression of prolyl isomerase Pin1 in human cancers. Am. J. Pathol. 2004, 164, 1727-1737.
136. Liou, Y.C.; Ryo, A.; Huang, H.K.; Lu, P.J.; Bronson, R.; Fujimori, F.; Uchida, T.; Hunter, T.; Lu, K.P. Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes. Proc. Natl. Acad. Sci. USA 2002, 99, 1335-1340.
137. Xu, Y.X.; Hirose, Y.; Zhou, X.Z.; Lu, K.P.; Manley, J.L. Pin1 modulates the structure and function of human RNA polymerase II. Genes Dev. 2003, 17, 2765-2776.
138. Wildemann, D.; Hernandez Alvarez, B.; Stoller, G.; Zhou, X.Z.; Lu, K.P.; Erdmann, F.; Ferrari, D.; Fischer, G. An essential role for Pin1 in Xenopus laevis embryonic development revealed by specific inhibitors. Biol. Chem. 2007, 388, 1103-1111.
139. Lee, T.H.; Tun-Kyi, A.; Shi, R.; Lim, J.; Soohoo, C.; Finn, G.; Balastik, M.; Pastorino, L.; Wulf, G.; Zhou, X.Z.; Lu, K.P. Essential role of Pin1 in the regulation of TRF1 stability and telomere maintenance. Nat. Cell Biol. 2009, 11, 97-105.
140. Raghuram, N.; Strickfaden, H.; McDonald, D.; Williams, K.; Fang, H.; Mizzen, C.; Hayes, J.J.; Th'ng, J.; Hendzel, M.J. Pin1 promotes histone H1 dephosphorylation and stabilizes its binding to chromatin. J. Cell Biol. 2013, 203, 57-71.
141. Krishnan, N.; Titus, M.A.; Thapar, R. The prolyl isomerase pin1 regulates mRNA levels of genes with short half-lives by targeting specific RNA binding proteins. PLoS One 2014, 9, e85427.
142. Wulf, G.; Garg, P.; Liou, Y.C.; Iglehart, D.; Lu, K.P. Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis. EMBO J. 2004, 23, 3397-3407.
143. Kim, C.J.; Cho, Y.G.; Park, Y.G.; Nam, S.W.; Kim, S.Y.; Lee, S.H.; Yoo, N.J.; Lee, J.Y.; Park, W.S. Pin1 overexpression in colorectal cancer and its correlation with aberrant beta-catenin expression. World J. Gastroenterol. 2005, 11, 5006-5009.
144. Ryo, A.; Uemura, H.; Ishiguro, H.; Saitoh, T.; Yamaguchi, A.; Perrem, K.; Kubota, Y.; Lu, K.P.; Aoki, I. Stable suppression of tumorigenicity by Pin1-targeted RNA interference in prostate cancer. Clin. Cancer Res. 2005, 11, 7523-7531.
145. Wang, H.; Zhang, J.; Feng, W.; Zhang, S.; Liang, H.; Wang, Y.; Zheng, Q.; Li, Z. PIN1 gene overexpression and beta-catenin gene mutation/expression in hepatocellular carcinoma and their significance. J. Huazhong Univ. Sci. Technolog. Med. Sci. 2007, 27, 54-57.
146. Kim, M.R.; Choi, H.S.; Heo, T.H.; Hwang, S.W.; Kang, K.W. Induction of vascular endothelial growth factor by peptidyl-prolyl isomerase Pin1 in breast cancer cells. Biochem. Biophys. Res. Commun. 2008, 369, 547-553.
147. Rustighi, A.; Tiberi, L.; Soldano, A.; Napoli, M.; Nuciforo, P.; Rosato, A.; Kaplan, F.; Capobianco, A.; Pece, S.; Di Fiore, P.P.; Del Sal, G. The prolyl-isomerase Pin1 is a Notch1 target that enhances Notch1 activation in cancer. Nat. Cell Biol. 2009, 11, 133-142.
148. Khanal, P.; Kim, G.; Yun, H.J.; Cho, H.G.; Choi, H.S. The prolyl isomerase Pin1 interacts with and downregulates the activity of AMPK leading to induction of tumorigenicity of hepatocarcinoma cells. Mol. Carcinog. 2013, 52, 813-823.
149. Suizu, F.; Ryo, A.; Wulf, G.; Lim, J.; Lu, K.P. Pin1 regulates centrosome duplication, and its overexpression induces centrosome amplification, chromosome instability, and oncogenesis. Mol. Cell Biol. 2006, 26, 1463-1479.
150. Atkinson, G.P.; Nozell, S.E.; Harrison, D.K.; Stonecypher, M.S.; Chen, D.; Benveniste, E.N. The prolyl isomerase Pin1 regulates the NF-kappaB signaling pathway and interleukin-8 expression in glioblastoma. Oncogene 2009, 28, 3735-3745.
151. Lee, N.Y.; Choi, H.K.; Shim, J.H.; Kang, K.W.; Dong, Z.; Choi, H.S. The prolyl isomerase Pin1 interacts with a ribosomal protein S6 kinase to enhance insulin-induced AP-1 activity and cellular transformation. Carcinogenesis 2009, 30, 671-681.
152. Pulikkan, J.A.; Dengler, V.; Peer Zada, A.A.; Kawasaki, A.; Geletu, M.; Pasalic, Z.; Bohlander, S.K.; Ryo, A.; Tenen, D.G.; Behre, G. Elevated PIN1 expression by C/EBPalpha-p30 blocks C/EBPalpha-induced granulocytic differentiation through c-Jun in AML. Leukemia 2010, 24, 914-923.
153. Ayala, G.; Wang, D.; Wulf, G.; Frolov, A.; Li, R.; Sowadski, J.; Wheeler, T.M.; Lu, K.P.; Bao, L. The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer. Cancer Res. 2003, 63, 6244-6251.
154. Dochi, T.; Nakano, T.; Inoue, M.; Takamune, N.; Shoji, S.; Sano, K.; Misumi, S. Phosphorylation of human immunodeficiency virus type 1 (HIV-1) capsid protein at serine 16, required for peptidyl-prolyl isomerase (Pin1)-dependent uncoating, is mediated by virion-incorporated extracellular signal-regulated kinase 2 (ERK2). J. Gen. Virol. 2014, 95, 1156-1156.
155. Misumi, S.; Inoue, M.; Dochi, T.; Kishimoto, N.; Hasegawa, N.; Takamune, N.; Shoji, S. Uncoating of human immunodeficiency virus type 1 requires prolyl isomerase Pin1. J. Biol. Chem. 2010, 285, 25185-25195.
156. Watashi, K.; Khan, M.; Yedavalli, V.R.; Yeung, M.L.; Strebel, K.; Jeang, K.T. Human immunodeficiency virus type 1 replication and regulation of APOBEC3G by peptidyl prolyl isomerase Pin1. J. Virol. 2008, 82, 9928-9936.
157. Saitoh, T.; Tun-Kyi, A.; Ryo, A.; Yamamoto, M.; Finn, G.; Fujita, T.; Akira, S.; Yamamoto, N.; Lu, K.P.; Yamaoka, S. Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1. Nat. Immunol. 2006, 7, 598-605.
158. Lim, Y.S.; Tran, H.T.; Park, S.J.; Yim, S.A.; Hwang, S.B. Peptidyl-prolyl isomerase Pin1 is a cellular factor required for hepatitis C virus propagation. J. Virol. 2011, 85, 8777-8788.
159. Avila, M.A.; Lu, K.P. Hepatitis B virus x protein and pin1 in liver cancer: "les liaisons dangereuses".Gastroenterology 2007, 132, 1180-1183.
160. Chowdhury, I.H.; Radonovich, M.; Mahieux, R.; Pise-Masison, C.; Muralidhar, S.; Brady, J.N. P53 facilitates degradation of human T-cell leukaemia virus type I Tax-binding protein through a proteasome-dependent pathway. J. Gen. Virol. 2003, 84, 897-906.
161. Peloponese, J.M., Jr.; Yasunaga, J.; Kinjo, T.; Watashi, K.; Jeang, K.T. Peptidylproline cis-trans-isomerase Pin1 interacts with human T-cell leukemia virus type 1 tax and modulates its activation of NF-kappaB. J. Virol. 2009, 83, 3238-3248.
162. Milbradt, J.; Webel, R.; Auerochs, S.; Sticht, H.; Marschall, M. Novel mode of phosphorylation-triggered reorganization of the nuclear lamina during nuclear egress of human cytomegalovirus. J. Biol. Chem. 2010, 285, 13979-13989.
163. Ott, D.E.; Coren, L.V.; Johnson, D.G.; Kane, B.P.; Sowder, R.C., 2nd; Kim, Y.D.; Fisher, R.J.; Zhou, X.Z.; Lu, K.P.; Henderson, L.E. Actin-binding cellular proteins inside human immunodeficiency virus type 1. Virology 2000, 266, 42-51.
164. Kamimoto, T.; Zama, T.; Aoki, R.; Muro, Y.; Hagiwara, M. Identification of a novel kinesin-related protein, KRMP1, as a target for mitotic peptidyl-prolyl isomerase Pin1. J. Biol. Chem. 2001, 276, 37520-37528.
165. Narita, Y.; Murata, T.; Ryo, A.; Kawashima, D.; Sugimoto, A.; Kanda, T.; Kimura, H.; Tsurumi, T. Pin1 interacts with the Epstein-Barr virus DNA polymerase catalytic subunit and regulates viral DNA replication. J. Virol. 2013, 87, 2120-2127.
166. Guito, J.; Gavina, A.; Palmeri, D.; Lukac, D.M. The cellular peptidyl-prolyl cis/trans isomerase Pin1 regulates reactivation of Kaposi's sarcoma-associated herpesvirus from latency. J. Virol. 2014, 88, 547-558.
167. Gantt, S.; Carlsson, J.; Ikoma, M.; Gachelet, E.; Gray, M.; Geballe, A.P.; Corey, L.; Casper, C.; Lagunoff, M.; Vieira, J. The HIV protease inhibitor nelfinavir inhibits Kaposi's sarcoma-associated herpesvirus replication in vitro. Antimicrob. Agents Chemother. 2011, 55, 2696-2703.
168. Toth, Z.; Brulois, K.F.; Wong, L.Y.; Lee, H.R.; Chung, B.; Jung, J.U. Negative elongation factor-mediated suppression of RNA polymerase II elongation of Kaposi's sarcoma-associated herpesvirus lytic gene expression. J. Virol. 2012, 86, 9696-9707.
169. Feldman, D.E.; Chauhan, V.; Koong, A.C. The unfolded protein response: A novel component of the hypoxic stress response in tumors. Mol. Cancer Res. 2005, 3, 597-605.
170. Koumenis, C.; Bi, M.; Ye, J.; Feldman, D.; Koong, A.C. Hypoxia and the unfolded protein response. Methods Enzymol. 2007, 435, 275-293.
171. Cai, Q.L.; Knight, J.S.; Verma, S.C.; Zald, P.; Robertson, E.S. EC5S ubiquitin complex is recruited by KSHV latent antigen LANA for degradation of the VHL and p53 tumor suppressors. PLoS Pathog. 2006, 2, e116.
172. Long, E.; Ilie, M.; Hofman, V.; Havet, K.; Selva, E.; Butori, C.; Lacour, J.P.; Nelson, A.M.; Cathomas, G.; Hofman, P. LANA-1, Bcl-2, Mcl-1 and HIF-1alpha protein expression in HIV-associated Kaposi sarcoma. Virchows Arch. 2009, 455, 159-170.
173. Kim, M.R.; Choi, H.S.; Yang, J.W.; Park, B.C.; Kim, J.A.; Kang, K.W. Enhancement of vascular endothelial growth factor-mediated angiogenesis in tamoxifen-resistant breast cancer cells: role of Pin1 overexpression. Mol. Cancer Ther. 2009, 8, 2163-2171.
174. Ryo, A.; Nakamura, M.; Wulf, G.; Liou, Y.C.; Lu, K.P. Pin1 regulates turnover and subcellular localization of beta-catenin by inhibiting its interaction with APC. Nat. Cell Biol. 2001, 3, 793-801.
175. Cho, Y.S.; Park, S.Y.; Kim, D.J.; Lee, S.H.; Woo, K.M.; Lee, K.A.; Lee, Y.J.; Cho, Y.Y.; Shim, J.H. TPA-induced cell transformation provokes a complex formation between Pin1 and 90 kDa ribosomal protein S6 kinase 2. Mol. Cell Biochem. 2012, 367, 85-92.
176. Xu, Y.X.; Manley, J.L. Pinning down transcription: Regulation of RNA polymerase II activity during the cell cycle. Cell Cycle 2004, 3, 432-435.
177. Xu, Y.X.; Manley, J.L. Pin1 modulates RNA polymerase II activity during the transcription cycle. Genes Dev. 2007, 21, 2950-2962.
178. Wulf, G.M.; Liou, Y.C.; Ryo, A.; Lee, S.W.; Lu, K.P. Role of Pin1 in the regulation of p53 stability and p21 transactivation, and cell cycle checkpoints in response to DNA damage. J. Biol. Chem. 2002, 277, 47976-47979.
179. Zheng, H.; You, H.; Zhou, X.Z.; Murray, S.A.; Uchida, T.; Wulf, G.; Gu, L.; Tang, X.; Lu, K.P.; Xiao, Z.X. The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response. Nature 2002, 419, 849-853.
180. Liao, Y.; Wei, Y.; Zhou, X.; Yang, J.Y.; Dai, C.; Chen, Y.J.; Agarwal, N.K.; Sarbassov, D.; Shi, D.; Yu, D.; Hung, M.C. Peptidyl-prolyl cis/trans isomerase Pin1 is critical for the regulation of PKB/Akt stability and activation phosphorylation. Oncogene 2009, 28, 2436-2445.
181. Lu, P.J.; Zhou, X.Z.; Liou, Y.C.; Noel, J.P.; Lu, K.P. Critical role of WW domain phosphorylation in regulating phosphoserine binding activity and Pin1 function. J. Biol. Chem. 2002, 277, 2381-2384.
182. Lavoie, S.B.; Albert, A.L.; Handa, H.; Vincent, M.; Bensaude, O. The peptidyl-prolyl isomerase Pin1 interacts with hSpt5 phosphorylated by Cdk9. J. Mol. Biol. 2001, 312, 675-685.
183. Lan, K.; Verma, S.C.; Murakami, M.; Bajaj, B.; Kaul, R.; Robertson, E.S. Kaposi's sarcoma herpesvirus-encoded latency-associated nuclear antigen stabilizes intracellular activated Notch by targeting the Sel10 protein. Proc. Natl. Acad. Sci. USA 2007, 104, 16287-16292.
184. Kirshner, J.R.; Lukac, D.M.; Chang, J.; Ganem, D. Kaposi's sarcoma-associated herpesvirus open reading frame 57 encodes a posttranscriptional regulator with multiple distinct activities. J. Virol. 2000, 74, 3586-3597.